Helen Voelker
University of Minnesota
21 Papers
93 Citations
Helen Voelker is an academic researcher from University of Minnesota. The author has contributed to research in topics: COPD & Placebo. The author has an hindex of 11, co-authored 21 publications.
Chat about Author
Papers
Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
G.J. Criner,John E. Connett,Shawn D. Aaron,Richard K. Albert,William C. Bailey,Richard Casaburi,John A. D. Cooper,Jeffrey L. Curtis,Mark T. Dransfield,MeiLan K. Han,Barry J. Make,Nathaniel Marchetti,Fernando J. Martinez,Dennis E. Niewoehner,Paul D. Scanlon,Frank C. Sciurba,Steven M. Scharf,Don D. Sin,Helen Voelker,George R. Washko,Prescott G. Woodruff,Stephen C. Lazarus +21 more
TL;DR: Simvastatin at a daily dose of 40 mg did not affect exacerbation rates or the time to a first exacerbation in patients with COPD who were at high risk for exacerbations.
Metoprolol for the Prevention of Acute Exacerbations of COPD.
Mark T. Dransfield,Mark T. Dransfield,Helen Voelker,Surya P. Bhatt,Keith Brenner,Richard Casaburi,Carolyn E. Come,J. D.Allen Cooper,Gerard J. Criner,Jeffrey L. Curtis,MeiLan K. Han,Umur Hatipoğlu,Erika S. Helgeson,Vipul V. Jain,Ravi Kalhan,David A. Kaminsky,Robert J. Kaner,Ken M. Kunisaki,Allison A. Lambert,Matthew R. Lammi,Sarah M Lindberg,Barry J. Make,Fernando J. Martinez,Charlene McEvoy,Ralph J. Panos,Robert M. Reed,Paul D. Scanlon,Frank C. Sciurba,Anthony Smith,P. S. Sriram,William W. Stringer,Jeremy A. Weingarten,J. Michael Wells,Elizabeth Westfall,Stephen C. Lazarus,John E. Connett +35 more
TL;DR: Among patients with moderate or severe COPD who did not have an established indication for beta-blocker use, the time until the first COPD exacerbation was similar in the metoprolol group and the placebo group, as was the overall rate of nonrespiratory serious adverse events.
148
•Journal Article
Spirometry in the Lung Health Study
122
Weight gain as a function of smoking cessation and 2-mg nicotine gum use among middle-aged smokers with mild lung impairment in the first 2 years of the Lung Health Study.
Mitchell A. Nides,Cynthia S. Rand,Jeff Dolce,Robert P. Murray,Peggy O'Hara,Helen Voelker,John E. Connett +6 more
TL;DR: It is concluded that moderate weight gain is a long-term consequence of smoking cessation--a portion of which can be delayed with 2-mg nicotine gum.
85
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
Michael A. Puskarich,Michael A. Puskarich,Nathan W. Cummins,Nicholas E. Ingraham,David A. Wacker,Ronald Reilkoff,Brian E. Driver,Michelle H. Biros,M. Fernanda Bellolio,Jeffrey G. Chipman,Andrew C. Nelson,Kenneth B. Beckman,Ryan A. Langlois,Tyler D. Bold,Matthew T. Aliota,Timothy W. Schacker,Helen Voelker,Thomas A. Murray,Joseph S. Koopmeiners,Christopher J. Tignanelli,Christopher J. Tignanelli +20 more
TL;DR: In this article, a multicenter blinded randomized clinical trial (RCT) was conducted to test the efficacy of losartan on outpatients with mild symptomatic COVID-19 disease, though assessment was limited by low event rate.
60